March 3, 2008 - AirInSpace said last week it received FDA clearance to market its PlasmairT2006 mobile system as a medical device, the same technology that has been protecting astronauts aboard the International Space Station since 2000 against harmful particulates and microbes.
In October 2007, AirInSpace said it closed an $8.5 million Series “B” round of financing to fuel the company’s expansion into the U.S.